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A B S T R A C T
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin carcinoma¹. The purpose of this study is
to describe clinical and pathological characteristics, diagnostic procedure and treatment outcomes of the patients with
MCC of the head and neck treated in Otorhinolaryngology, Head and Neck Surgery Department of the University Hospi-
tal Center Zagreb between the years 2007 and 2011. Three patients with MCC of the head and neck were treated during
this period. First patient was diagnosed with MCC of the left retroauricular region with metastases in the lymph nodes of
the left side of the neck, pT2N2M0 Stage IIIB. Second patient was diagnosed with anaplastic carcinoma of the lower lip,
pT1N1bM0 Stage IIIB and third patient was diagnosed with MCC of the face which was previously treated as benign le-
sion, cT1N1bM0 Stage IIIB. Two of the patients had second primary tumor of different histology. All of the patients were
treated with wide surgical excision of the tumor and neck dissection combined with adjuvant radiotherapy. Treatment
outcome was poor and reason for this was late detection of disease. Menagment of the MCC patients requires multidis-
ciplinary approach with high clinical suspicion of the treating specialist and pathologist due to immunohistochemical
techniques required for diagnosis. Detection of the MCC in earlier stages is necessary for the better survival rate.
Key words: Merkel cell carcinoma, second primary tumor, wide surgical excision, treatment outcome, immunohis-
tochemical techniques
Introduction
Merkel cell carcinoma (MCC) is a rare neuroendo-
crine carcinoma of the skin which was first described by
Toker in 19721–4. Incidence ranges from 0.24 to 0.44 per
100 000 people per year1. Mostly, these tumors appear in
the 7th and 8th decade of life2. Risk factors are sun expo-
sure and immune supression, including chronic lympho-
cytic leukemia (CLL) and HIV1,3,4. The risk of second pri-
mary cancer following the diagnosis of MCC and the risk
of second primary MCC following other first primary
cancers was quantified in research of Howard et al. from
20065. They identified an increased risk for developing
Non-Hodgkin lymphoma (NHL) after MCC, but the risk
for developing CLL after MCC was not seen as statisti-
cally significant. In contrary, in research made by Koljo-
nen et al.3 from 2009 was reported significantly increa-
sed risk for developing CLL in patients diagnosed with
MCC. Also, in research from 2010 Koljonen et al.4 re-
ported that patients diagnosed with MCC have signifi-
cantly elevated risk for basal cell carcinoma of the skin
and CLL. This was explained as a consequence from
shared etiological factors between MCC and other tumor
types, such as immunosupression or possibly Merkel cell
polyomavirus infection3,4,6. Human polyomavirus discov-
ery is helping to understand pathogenesis of MCC and to
develope a new approach to the treatment of the disease6.
MCC is also known as apudoma of the skin, trabecular
cancer or small-cell neuroepithelial tumor of the skin.
When discovered was termed »trabecular carcinoma of
the skin« becasue of histopathologically described ana-
stomosing trabeculae and cell nests in the dermis6. No-
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menklature was changed to MCC after the tumor cells
were characterised by the presence of electron-dense
neurosecretory granules and Merkel cells are the only
type of cutaneous cells expressing such granules2,6. Three
histopathologic types are described- a trabecular form,
an intermediate one and the small cell type. Definitive di-
agnosis is established by positive staining for chromo-
granin, synpatophysin, neuron-specific enolase and the
neural cell adhesion molecule, which represents both epi-
thelial and neuroendocrine antigens present in normal
Merkel cells6. The expression of cytokeratin 20, found in
the tumor cells in a dot-like paranuclear pattern and
along the cytoskeleton, is the most characteristic sign for
the identification6. The most difficult differentiation is
often between primary MCC and metastatic small cell of
the lung7. CK-20 is very sensitive marker for MCC and
TTF-1 is positive in small cell lung cancer but is consis-
tently absent in MCC7 (Figure 1).
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Fig. 1. is showing pathohistological characteristics of MCC: a)
HE 100x: In the dermis under the intact epidermis the lobular
tumor is formed. b) HE 400x: tumor is composed of atipical tu-
mor cells with ambiguous cytoplasmic membranes and bright
large nucleus. c) AE1/3 400x: inside of the tumor pan-cytokeratin
positivity in a dot-like apperance of cytoplasmic stain. d) TTF
200x: negative TTF is excluding lung cancer. e) LCA 400x: nega-
tive LCA in tumor cells, positive in a few inflammatory cells of
the stroma is excluding lymphoma. HE-Hematoxylin-eosin,
AE1/3- Anti-Keratin AE1 and AE3, TTF-Thyroid Transcription
Factor 1, LCA-Leukocyte Common Antigen.
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In most of the cases (81%) MCC appears in the sun-
-exposed skin such as head and neck area and extremi-
ties6. Clinical presentation is not specific, but usually
presents as firm red-violet cutaneous tumor nodule1,6. In
56% of the cases the lesion is thought to be benign before
biopsy1. In contrary to the clinical presentation, MCC is
very aggressive tumor presenting with high grade local
recurrence and regional lymph node metastases.
Treatment options include wide surgical excision with
or without regional lymph node dissection, radiotherapy
and chemoterapy. The purpose of this article is to discuss
diagnostic procedure and treatment outcomes of three
different patients treated in our institution.
Case Reports
From the year 2007 to 2011 three different patients
were treated in Otrhinolaryngology, Head and Neck Sur-
gery Department of the Zagreb University Hospital Cen-
ter. Tumor staging system described by the American
Joint Committee on Cancer, 7th ed., 2010 was used.
First patient, 87 years old, male, was diagnosed with
MCC of the left retroauricular area with the metastases
in the cervical lymphnodes of the left side, pT2N2M0
Stage IIIB. The patient noticed a tumor behind left auri-
cle 4 months before the check up and swelling on the left
side of the neck in the last 2 months. From the history of
disease there were no other malignances reported. In the
local status an exofitic lesion, size 3x3 cm with the areas
of ulcerations and necrosis. On the left side of the neck in
level V appears conglomerate of lymphnodes, size 4x4
cm, hard and fixed to the surrounding area. Preoperative
ultrasonography and fine needle aspiration biopsy of the
conglomerate with immunocytochemistry showed CK 20
positive, chromogranin positive and LCA negative malig-
nant cells highly specific for Merkel cell carcinoma. Pre-
operative CT scan was also performed. The treatment
was wide local excision of the tumor and left auricle en
bloc, left radical neck dissection and total left parotidec-
tomy. Pathohistological analysis showed a tumor 4,5x3
cm infiltrating retroauricular area and fat tissue of the
parotid area. In total were 17 lymphnodes with conglom-
erate removed among which were 13 lymphnodes with
conglomerate infiltrated with the tumor. Adjuvant radio-
therapy was performed. The patient died 6 months after
the surgery from cardiac failure.
Second patient, 64 years old, female, with a tumor of
the lower lip. She was operated under the local anesthe-
sia in the other institution. Pathohistological analysis
showed anaplastic carcinoma with free margins. Three
weeks after she palpated enlarged lymphnodes of the
right side of the neck and she was recieved in our Depart-
ment with the tumor pT1N1bM0 Stage IIIB. From the
history of disease: thirteen years ago she was operated
because of the breast cancer and recieved adjuvant che-
moradiotherapy. Two years ago she was diagnosed with
NHL, she recieved chemotherapy. Preoperative CT scan
showed two enlarged lymphondes in the right submandi-
bular region and fine needle aspiration biopsy confirmed
metastases of poorly differentiated carcinoma.
The treatment was right radical neck dissection. Pa-
thohistological analysis showed 28 lymphnodes and con-
glomerate in total and 11 lymphnodes from the levels I-V
with the conglomerate were infiltrated with Merkel cell
carcinoma. Postoperative chemoradiotherapy was plan-
ned.
One month after the right radical neck dissection the
patient discovered enlarged lymphnodes of the left sub-
mandibular area. Fine needle aspiration biopsy showed
metastases of the poorly differentiated carcinoma. The
tratment was left extended supraomohyoid neck dissec-
tion. Patohistological analysis of the neck levelss I-IV
showed 20 lymphnodes in total and 3 lymphnodes were
infiltrated with Merkel cell carcinoma. Postoperative che-
moradiotherapy was performed. Patient died 5 months
after the second surgery.
Third patient, 77 years old, female, with a small yel-
lowish lession on the right cheek at first was treated as
benign lesion suspected to atheroma. Under the local an-
esthesia excision of the lesion was performed, pathohis-
tological analysis showed cutaneous Merkel cell carci-
noma with positive margins. One month later she was
recieved in our Department for the surgical reexcision
(Figure 2). In the physical status of the neck there were
enlarged lymphnodes in the level V bilaterally and in the
level I on the left side of the neck enlarged one lymph-
node, cT1N1bM0 Stage IIIB.
Preoperative CT scan (Figure 3 and 4) was performed.
Fine needle aspiration biopsy discovered metastases
of the MCC in the right submandibular lymphnodes and
hypreplasia of the lymphocytes in the neck lymphnodes
bilaterally. During the hospitalisation leukocytosis was
discovered and NHL was diagnosed. The treatment in-
cluded wide surgical reexcision and right radical neck
dissection (Figure 5 and 6). Pathohistological analysis
showed tumor size 1 cm which is infiltrating subcutane-
ous fat tissue and skeletal musculature, the base of the
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Fig. 2. Third patient: After the surgical excision in the right cheek
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preparation was positive with tumor tissue. MCC was
also found in the fat tissue of the right submandibular
area. Lymphnodes from the level 1 to V were free from
MCC, but were infiltrated with tumor tissue described as
NHL, B-small lymphocytic lymphoma. After the surgical
treatment, radiotherapy is planned. Patient was trans-
fered to Hematology Department for the further treat-
ment which is still on.
Discussion
There is no well defined menagement for the patients
with cutaneous MCC. The patients treated in our institu-
tion were very different in the clinical presentation of the
disease, comorbidities and the presence of the second pri-
mary tumor. None of them at the beginning of the treat-
ment was suspected to be diagnosed with MCC and all of
them were recieved in our institution in Stage III of the
disease. The rarity of the disease, aggressive nature and
it’s pathohistological characteristics are the reasons why
the diagnosis is confirmed in the later stages. The com-
plete examination of the suspicious lesion of the skin and
high awareness of the specialist together with patholo-
gist should be the initial work up. The primary treat-
ment was surgical. We performed local wide excision with
clear lateral surgical margins. In preoperative manage-
ment we were using CT scan and ultrasonography with
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Fig. 3. Third patient: CT scan showing in the right cheek area
postoperative irregularities and oval solid mass size 8 mm in
diametar which represents residual tumor tissue
Fig. 4. Third patient: CT scan showing enlarged lymphnodes bi-
laterally.
Fig. 5. Third patient: Wide surgical reexcision
Fig. 6. Third patient: Radical neck dissection.
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fine needle biopsy of the suspicious lymph nodes which
resulted to be very specific in detection of positive re-
gional lymph nodes metastases. The neck dissection was
performed due to the results of biopsy. Many authors
suggest sentinel lymph node biopsy as important in stag-
ing and treatment of the MCC9. Also, Mohs surgery is ad-
visable to reduce local persistence of the disease8.
Adjuvant radiotherapy was carried out in all our
ptients and is mostly used to minimaze a locoregional
recurrence10. Chemotherapy doesn’t improve overall sur-
vival11. Tumor staging is the most important prognostic
factor12. The patients treated in our institution were all
Stage III of the disease with poor prognosis and outcome.
Associated second primary cancers such as NHL in
our two patients, one diagnosed before MCC and the
other simultaneously with MCC supports research re-
sults from Howard et al.5 from 2006.
Conclusion
MCC is aggressive neuroendocrine skin tumor closely
associated with the other cancers, mainly squamous skin
carcinoma, NHL and CLL. Two of our patients support
this association. Recognition of connection betweenMCC
and other malignancies should be includeed in diagnostic
protocol of MCC menagement.
Patients treated in our institution had bad outcome in
spite of wide surgical excision, radical neck dissection
and adjuvant radiotherapy. The reason for that is detec-
tion of the disease in Stage III. Detection of the MCC in
earlier stages is necessary for the better survival rate.
The treatment requires multidisciplinary approach with
high clinical suspicion of the treating specialist and pa-
thologist due to immunohistochemical techniques re-
quired for diagnosis.
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KARCINOM MERKELOVIH STANICA GLAVE I VRATA I PRIDRU@ENI SEKUNDARNI PRIMARNI
KARCINOMI: PRIKAZ TRI SLU^AJA
S A @ E T A K
Karcinom Merkelovih stanica (KMS) je rijedak i agresivan neuroendokrini karcinom ko`e¹. Cilj ove studije je opisati
klini~ke i patohistolo{ke karakterisitike kao i dijagnosti~ki protokol i ishod lije~enja pacijenata sa KMS glave i vrata
lije~enih na Odjelu za otorinolaringologiju i kirurgiju glave i vrata Klini~kog bolni~kog centra Zagreb u periodu od 2007.
do 2011. godine. Tri pacijenta sa KMS glave i vrata lije~eno je u ovom periodu. Prvom pacijentu je dijagnosticiran KMS
lijeve retroaurikularne regije sa metastazama u limfne ~vorove lijeve strane vrata, pT2N2M0 Stadij IIIB. Drugom paci-
jentu je dijagnosticiran anaplasti~ni karcinom donje usne, pT1N1bM0 Stadij IIIB, a tre}em pacijentu je dijagnosticiran
KMS na licu koji je prethodno tretiran kao benigna lezija, cT1N1bM0 Stadij IIIB. Dva pacijenta su imala drugi primarni
tumor razli~ite histologije. Svi pacijenti su bili lije~eni kirur{ki. U~injena je {iroka ekscizija tumora i disekcija vrata u
kombinaciji s adjuvantnom radioterapijom. Ishod lije~enja je bio lo{, a razlog tome je kasno otkrivanje bolesti. Lije~enje
pacijenata sa KMS zahtijeva multidisciplinaran pristup sa visokom klini~kom sumnjom specijaliste odgovornog za lije-
~enje i patologa vezano za imunohistokemijske tehnike potrebne za dijagnozu. Otkrivanje KMS u ranijim stadijima je
nu`no kako bi se postigla bolja stopa pre`ivljenja.
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